XML 55 R43.htm IDEA: XBRL DOCUMENT v3.20.2
Subsequent Events (Details) - Subsequent Event [Member] - $ / shares
1 Months Ended
Jul. 02, 2020
Jul. 23, 2020
Jul. 09, 2020
Subsequent event, description Employees were granted options to purchase an aggregate of 25,700 shares of the Company’s Common Stock with an exercise price of $28.20 per share. These options expire ten years from the date of grant and vests 25% on June 29, 2021 and the remainder of the underlying shares shall vest in thirty-six equal monthly installments thereafter.    
Dr. Flannelly [Member] | Stock Option [Member]      
Purchase shares of common stock   18,000  
Exercise price per share   $ 26.70  
Grant date   10 years  
Dr. Flannelly [Member] | Stock Option One [Member]      
Purchase shares of common stock   8,250  
Exercise price per share   $ 26.70  
Grant date   10 years  
Restricted Stock Units (RSUs) [Member]      
Subsequent Events (Textual) The Compensation Committee of the Company granted 7,500 RSUs to a new hire of the Company under the 2014 Equity Incentive Plan. These RSUs will vest 25% on the one, two, three and four year anniversary of the date of grant. The Company and Dr. Casoy entered into a Separation Agreement and Release (the "Separation Agreement"), whereupon Dr. Casoy will no longer be employed by the Company as Chief Medical Officer, effective August 3, 2020. Pursuant to the Separation Agreement, in consideration of a general release of all claims against the Company and certain representations, warranties, covenants and agreements, Dr. Casoy is entitled to receive (i) his base salary for a period of nine months paid in a lump sum, (ii) a one-time lump sum payment equal to nine months of his bonus at target, (iii) reimbursement of all business expenses for which he is entitled, (iv) reimbursement of COBRA premium costs for nine months, or until he has secured other employment, whichever comes first and (v) pro-rata vesting of his outstanding equity award given that he was not employed through the one-year anniversary of the applicable grant date of such outstanding equity award.  
Shares of common stock from settlement of RSUs     5,245